| Orathecin (rubitecan) / Vivacitas |
NCT00005826: Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme |
|
|
| Completed | 2 | 17 | Europe | rubitecan | European Organisation for Research and Treatment of Cancer - EORTC | Brain and Central Nervous System Tumors | 09/00 | | | |
NCT00006026: Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract |
|
|
| Completed | 2 | 21 | Europe, RoW | rubitecan | European Organisation for Research and Treatment of Cancer - EORTC | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | 10/01 | | | |
NCT00006082: Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer |
|
|
| Completed | 2 | 38 | Europe | rubitecan | European Organisation for Research and Treatment of Cancer - EORTC | Lung Cancer | 08/02 | | | |
NCT00006230: Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer |
|
|
| Completed | 2 | 51 | Europe, RoW | rubitecan | European Organisation for Research and Treatment of Cancer - EORTC | Ovarian Cancer | 04/03 | | | |
NCT00005875: Nitrocamptothecin in Treating Patients With Metastatic Melanoma |
|
|
| Completed | 2 | | US | rubitecan | Astex Pharmaceuticals, Inc. | Melanoma (Skin) | | 04/04 | | |
NCT00005872: Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer |
|
|
| Completed | 2 | | US | rubitecan | Astex Pharmaceuticals, Inc. | Lung Cancer | | 04/04 | | |
NCT00005874: Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas |
|
|
| Completed | 2 | | US | rubitecan | Astex Pharmaceuticals, Inc. | Gastrointestinal Stromal Tumor, Sarcoma, Small Intestine Cancer | | 04/04 | | |
NCT00005873: Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer |
|
|
| Completed | 2 | | US | rubitecan | Astex Pharmaceuticals, Inc. | Breast Cancer | | 04/04 | | |
NCT00006267: Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer |
|
|
| Withdrawn | 2 | 0 | US | rubitecan | Gynecologic Oncology Group, National Cancer Institute (NCI) | Ovarian Cancer, Primary Peritoneal Cavity Cancer | 05/06 | | | |
NCT00005877: Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer |
|
|
| Unknown status | 2 | | US | rubitecan | Astex Pharmaceuticals, Inc. | Colorectal Cancer | | | | |
NCT00005876: Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery |
|
|
| Unknown status | 2 | | US | rubitecan | Astex Pharmaceuticals, Inc. | Esophageal Cancer, Gastric Cancer | | | | |
